Risk of Severe COVID-19 Outcomes Among Patients with Immune-Mediated Inflammatory Diseases or Malignancies: A Retrospective Analysis of Real-World Data in the United States

INTRODUCTION: There are concerns that patients in an immunocompromised state may be at risk for increased coronavirus disease 2019 (COVID-19) severity. The aim of this study was to describe the characteristics of patients with COVID-19 and immune-mediated inflammatory diseases (IMIDs) or malignancie...

Descripción completa

Detalles Bibliográficos
Autores principales: Yue, Xiaomeng, Ye, Yizhou, Choi, Yookyung C., Zhang, Dongmu, Krueger, Whitney S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510569/
https://www.ncbi.nlm.nih.gov/pubmed/36153800
http://dx.doi.org/10.1007/s12325-022-02293-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510569/
https://www.ncbi.nlm.nih.gov/pubmed/36153800
http://dx.doi.org/10.1007/s12325-022-02293-0

Ejemplares similares